Julie Krop's most recent trade in Aquestive Therapeutics Inc was a trade of 42,000 Stock Option (Right to Purchase) done . Disclosure was reported to the exchange on June 11, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Aquestive Therapeutics Inc | Julie Krop | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2025 | 42,000 | 42,000 | - | - | Stock Option (Right to Purchase) | |
| Aquestive Therapeutics Inc | Julie Krop | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2024 | 38,000 | 38,000 | - | - | Stock Option (Right to Purchase) | |
| Aquestive Therapeutics Inc | Julie Krop | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jun 2023 | 25,000 | 25,000 | - | - | Stock Option (Right to Purchase) | |
| Aquestive Therapeutics Inc | Julie Krop | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 25,000 | 25,000 | - | - | Stock Option (Right to Purchase) | |
| Aquestive Therapeutics Inc | Julie Krop | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2021 | 20,000 | 20,000 | - | - | Stock Option (Right to Purchase) | |
| Aquestive Therapeutics Inc | Julie Krop | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Mar 2021 | 28,500 | 28,500 | - | - | Non-Qualified Stock Option (right to buy) |